Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of local anesthetic mixtures with Tergase in ophthalmic regional anesthesia
KCT0012168Phase 3Recruiting
- Sponsor
- Alteogen
- Start
- Jun 2026
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of tergase in retinal diseases, sponsored by Alteogen. Started Jun 2026; status: recruiting.
02
Drugs
tergase
03
Conditions
retinal diseases
Beyond the preview
Go deeper on KCT0012168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0012168.